Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

BACKGROUND: Treatment decisions in asthma are based on assessments of symptoms and simple measures of lung function, which do not relate closely to underlying eosinophilic airway inflammation. We aimed to assess whether a management strategy that minimises eosinophilic inflammation reduces asthma e...

Full description

Bibliographic Details
Main Authors:	Green, R, Brightling, C, McKenna, S, Hargadon, B, Parker, D, Bradding, P, Wardlaw, A, Pavord, I
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
by: Siva, R, et al.
Published: (2007)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
by: Haldar, P, et al.
Published: (2009)

Asthma exacerbations and sputum eosinophil counts.
by: Currie, G, et al.
Published: (2003)

Sputum eosinophilia in idiopathic pulmonary fibrosis.
by: Birring, S, et al.
Published: (2005)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
by: Berry, M, et al.
Published: (2004)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma.
by: Brightling, C, et al.
Published: (2000)

Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma
by: Brightling, C, et al.
Published: (2000)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
by: Shrimanker, R, et al.
Published: (2017)

Exacerbations of severe asthma in patients treated with mepolizumab
by: Shrimanker, R, et al.
Published: (2018)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
by: Berry, M, et al.
Published: (2007)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
by: Siddiqui, S, et al.
Published: (2007)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
by: Brightling, C, et al.
Published: (2003)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
by: Bilocca, D, et al.
Published: (2017)

Observational study of the natural history of eosinophilic bronchitis.
by: Berry, M, et al.
Published: (2005)

Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
by: Brightling, C, et al.
Published: (2005)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
by: Green, R, et al.
Published: (2002)

Mepolizumab in refractory eosinophilic asthma.
by: Pavord, I, et al.
Published: (2010)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
by: Haldar, P, et al.
Published: (2014)

The significance of eosinophilic airway inflammation in asthma
by: Pavord, I, et al.
Published: (2002)

Induced sputum inflammatory mediator concentrations in chronic cough.
by: Birring, S, et al.
Published: (2004)

Eosinophils in asthma and other allergic diseases.
by: Wardlaw, A, et al.
Published: (2000)

The influence of age on induced sputum differential cell counts in normal subjects.
by: Thomas, R, et al.
Published: (2004)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
by: Haldar, P, et al.
Published: (2014)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
by: Haldar, P, et al.
Published: (2014)

Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations
by: Afia Aziz-Ur-Rehman, et al.
Published: (2017-04-01)

Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
by: Saha, S, et al.
Published: (2008)

Non-eosinophilic corticosteroid unresponsive asthma.
by: Pavord, I, et al.
Published: (1999)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
by: Brightling, C, et al.
Published: (2002)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
by: Shrimanker, R, et al.
Published: (2017)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
by: Shaw, D, et al.
Published: (2007)

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
by: Agbetile, J, et al.
Published: (2012)

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.
by: Brightling, C, et al.
Published: (2000)

Eosinophils in asthma and airway hyperresponsiveness.
by: Brightling, C, et al.
Published: (2004)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
by: Shrimanker, R, et al.
Published: (2017)

Evidence of a role of tumor necrosis factor alpha in refractory asthma.
by: Berry, M, et al.
Published: (2006)

New insights into the role of the mast cell in asthma.
by: Brightling, C, et al.
Published: (2003)

Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
by: Brightling, C, et al.
Published: (1999)

Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.
by: Bafadhel, M, et al.
Published: (2012)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
by: Green, R, et al.
Published: (2006)

New insights into the relationship between airway inflammation and asthma.
by: Wardlaw, A, et al.
Published: (2002)